Barrett's esophagus is a condition in which normal cells that line the esophagus, called squamous cells, turn a different cell type called specialized columnar cells. Damage to the lining of the esophagus from gastroesophageal reflux disease causes the cells to change. Less than 1 percent of people with this condition develop cancer of the esophagus. However, having Barrett's esophagus may increase the risk of developing esophageal cancer.
Did you know?
- Approximately 10% of patients with chronic reflux have Barrett’s esophagus, and the prevalence of the condition in a recent population study was 1.6%. The condition is associated with an increased risk of esophageal cancer.
- The incidence of esophageal cancer has increased by more than 400% since the 1970s.
- The cancer remains highly lethal, with a 5-year survival rate of less than 15%.
Because of the reasons listed above, Beaumont is proud to offer the screening and treatment of Barrett's esophagus. We believe that prevention, screenings and early treatment will ultimately mean a longer, healthier life.
Whether you are currently a patient, have some symptoms of Barrett's esophagus and would like a screening or are a physician that would like to refer a patient, you can rest easy knowing that our expansive team of health care professionals will give you the analysis and knowledge you need.
Beaumont Team Approach to Barrett's Esophagus
Beaumont is proud to offer a comprehensive, multi-disciplinary team approach to the screening and treating of patients with Barrett's esophagus. Comprised of a team of nurses, clinical navigators, thoracic surgeons, gastroenterologists and a dedicated pathologist, our program includes patient education, screening, evaluation and treatment when necessary. Currently, we are the only mutli-disciplinary Barrett's esophagus treatment team in Michigan.
Barrett's Esophagus Articles
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
The New England Journal of Medicine